BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27987042)

  • 1. Using dendritic cells to evaluate how Burkholderia cenocepacia clonal isolates from a chronically infected cystic fibrosis patient subvert immune functions.
    Guadalupe Cabral M; Pereira M; Silva Z; Iria I; Coutinho C; Lopes A; Sá-Correia I; Videira PA
    Med Microbiol Immunol; 2017 Apr; 206(2):111-123. PubMed ID: 27987042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of innate immune cell functions by the Burkholderia cepacia complex: Burkholderia cenocepacia but not Burkholderia multivorans disrupts maturation and induces necrosis in human dendritic cells.
    MacDonald KL; Speert DP
    Cell Microbiol; 2008 Oct; 10(10):2138-49. PubMed ID: 18624797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis.
    Miller RR; Hird TJ; Tang P; Zlosnik JE
    PLoS One; 2015; 10(11):e0143472. PubMed ID: 26599356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.
    Coutinho CP; Dos Santos SC; Madeira A; Mira NP; Moreira AS; Sá-Correia I
    Front Cell Infect Microbiol; 2011; 1():12. PubMed ID: 22919578
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hassan AA; Coutinho CP; Sá-Correia I
    Front Cell Infect Microbiol; 2019; 9():273. PubMed ID: 31417878
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation.
    Mesureur J; Feliciano JR; Wagner N; Gomes MC; Zhang L; Blanco-Gonzalez M; van der Vaart M; O'Callaghan D; Meijer AH; Vergunst AC
    PLoS Pathog; 2017 Jun; 13(6):e1006437. PubMed ID: 28651010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host evasion by Burkholderia cenocepacia.
    Ganesan S; Sajjan US
    Front Cell Infect Microbiol; 2011; 1():25. PubMed ID: 22919590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs.
    Truxova I; Pokorna K; Kloudova K; Partlova S; Spisek R; Fucikova J
    Immunol Lett; 2014 Jul; 160(1):39-49. PubMed ID: 24726860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkholderia cenocepacia-induced delay of acidification and phagolysosomal fusion in cystic fibrosis transmembrane conductance regulator (CFTR)-defective macrophages.
    Lamothe J; Valvano MA
    Microbiology (Reading); 2008 Dec; 154(Pt 12):3825-3834. PubMed ID: 19047750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia.
    Mil-Homens D; Bernardes N; Fialho AM
    FEMS Microbiol Lett; 2012 Mar; 328(1):61-9. PubMed ID: 22150831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Burkholderia cenocepacia Type VI Secretion System Effector TecA Is a Virulence Factor in Mouse Models of Lung Infection.
    Loeven NA; Perault AI; Cotter PA; Hodges CA; Schwartzman JD; Hampton TH; Bliska JB
    mBio; 2021 Oct; 12(5):e0209821. PubMed ID: 34579569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method for investigating Burkholderia cenocepacia infections in patients with cystic fibrosis and other chronic diseases of the airways.
    Wijers CD; Vagedes R; Weingart C
    BMC Microbiol; 2016 Sep; 16(1):200. PubMed ID: 27586172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of MMP-9 by human lung epithelial cells in response to the cystic fibrosis-associated pathogen Burkholderia cenocepacia reduced wound healing in vitro.
    Wright C; Pilkington R; Callaghan M; McClean S
    Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L575-86. PubMed ID: 21743026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis.
    Abdulrahman BA; Khweek AA; Akhter A; Caution K; Kotrange S; Abdelaziz DH; Newland C; Rosales-Reyes R; Kopp B; McCoy K; Montione R; Schlesinger LS; Gavrilin MA; Wewers MD; Valvano MA; Amer AO
    Autophagy; 2011 Nov; 7(11):1359-70. PubMed ID: 21997369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance.
    Coutinho CP; Barreto C; Pereira L; Lito L; Melo Cristino J; Sá-Correia I
    J Med Microbiol; 2015 Aug; 64(8):927-935. PubMed ID: 26002942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
    Drevinek P; Mahenthiralingam E
    Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of Burkholderia cenocepacia at the time of cepacia syndrome: loss of motility as a marker of poor prognosis?
    Kalferstova L; Kolar M; Fila L; Vavrova J; Drevinek P
    J Clin Microbiol; 2015 May; 53(5):1515-22. PubMed ID: 25694518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of Burkholderia cenocepacia virulence potential during cystic fibrosis chronic lung infection.
    Moreira AS; Mil-Homens D; Sousa SA; Coutinho CP; Pinto-de-Oliveira A; Ramos CG; Dos Santos SC; Fialho AM; Leitão JH; Sá-Correia I
    Virulence; 2017 Aug; 8(6):782-796. PubMed ID: 27652671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia cenocepacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient.
    Coutinho CP; de Carvalho CC; Madeira A; Pinto-de-Oliveira A; Sá-Correia I
    Infect Immun; 2011 Jul; 79(7):2950-60. PubMed ID: 21536796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.
    Kovats S; Turner S; Simmons A; Powe T; Chakravarty E; Alberola-Ila J
    Clin Exp Immunol; 2016 Nov; 186(2):214-226. PubMed ID: 27513522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.